NCPA Reacts to RFK Nomination to HHS

Key Takeaways

The NCPA supports Robert F. Kennedy, Jr.'s nomination, citing his history of challenging powerful corporations for citizens and small businesses.
Independent pharmacies, crucial to public health, face threats from anticompetitive practices by PBMs and insurers managing Medicare Part D.
The decline of independent pharmacies is causing pharmacy deserts, necessitating intervention from the new administration to address these issues.

Making America Healthy Again should start with PBM reform

The National Community Pharmacists Association issued the following statement on behalf of CEO B. Douglas Hoey in reaction to President-elect Donald Trump’s nomination of Robert F. Kennedy, Jr. as Health and Human Services secretary:

“We congratulate Kennedy on his nomination. We are encouraged by his lifelong willingness to take on the biggest and most powerful corporations on behalf of citizens and small businesses. We are eager to work with him and his team to educate them about how one of the country’s most important public health assets – the 19,000 independent pharmacies across the country – are in great jeopardy because of the unfair, anticompetitive business practices of PBMs and insurers that administer Medicare Part D for millions of seniors. Those pharmacies are disappearing, and pharmacy deserts are forming, because of the business practices of the PBMs and Big Insurance, and we very much hope Kennedy and the Trump administration will support our effort to rein in these bad actors.”